Followers | 603 |
Posts | 24107 |
Boards Moderated | 3 |
Alias Born | 12/06/2009 |
![](https://investorshub.advfn.com/uicon/179815.png?cb=1507260933)
Wednesday, July 12, 2017 7:00:49 PM
Virosomes are biodegradable, biocompatible, and non-toxic 13
Virosome technique is approved by the FDA for human use with a high safety profile.No risk of disease transmission
No chances of autoimmunogenity or anaphylaxis 18
Capable of delivering the drug into the cytoplasm of target cell
Broadly applicable to anticancer drugs, proteins, peptides, nucleic acids, antibiotics, fungicides)
Provides protection to drugs from degradation
Promotes fusion activity in the endolysosomal pathway
Characterization of Virosomes:
Detection of protein: sodium dodecyl-sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) can confirm the presence of HA protein in the virosomes 19.
Fusion activity: virosomes exhibit pH-dependent membrane fusion activity similar to native influenza virus and can be visualized with a fluorescent resonance energy transfer assay (RET) 18. Fusion activity can also be monitored indirectly by determining hemolytic activity, which indirectly corresponds to fusion activity and shows pH dependence similar to that of fusion 11.
Structure and size: Negative-stain electron microscopy generally used to determine ultrastructure and size of virosomes. The staining solution is of neutral pH, to avoid acid-induced conformational changes of HA 20.
Virosome Structure: Virosomes are spherical unilamellar vesicles with a mean diameter of around 150 nm. Influenza virus is most commonly used for virosome production.
Virosomes cannot replicate but are pure fusion-active vesicles. In contrast to liposomes, virosomes contain functional viral envelope glycoproteins: influenza virus hemagglutinin (HA) and neuraminidase (NA) are intercalated within the phospholipid bilayer membrane.
Further characteristics of virosomes depend on the choice of bilayer components. Virosomes can be optimized for maximal incorporation of the drug or for the best physiological effect by modifying the content or type of membrane lipids used. It is even possible to generate carriers for antisense-oligonucleotides or other genetic molecules, depending on whether positively or negatively loaded phospholipids are incorporated into the membrane.
Various ligands, such as cytokines, peptides, and monoclonal antibodies (MAbs) can be incorporated into the virosome and displayed on the virosomal surface. Even tumor-specific monoclonal antibody fragments (Fab) can be linked to virosomes to direct the carrier to selected tumor cells 21.
http://ijpsr.com/bft-article/virosomes-a-novel-vaccination-technology/?view=fulltext
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM